Award
Delivery Order #SPE2D226F1212
Delivery Order for Erythromycin Ophthalmic to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$630.00
Ceiling
$630.00
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 11, 2026
Identifier
SPE2D226F1212
NAICS
325411
This delivery order contract has been awarded to DMS Pharmaceutical Group Inc., a key pharmaceutical manufacturer and distributor, under an existing long-term indefinite delivery vehicle (IDV) contract. The order focuses on the procurement of erythromycin ophthalmic products to meet specific government healthcare needs. The significance of this award lies in its role in ensuring the continuous and timely availability of essential antibiotic treatments, which are critical for protecting public health. The scope of work encompasses delivery of this specific pharmaceutical product to support government healthcare facilities, leveraging the established framework of the parent IDV which facilitates streamlined acquisition. This award was executed under a competitive long-term contract vehicle, demonstrating the agency's commitment to securing reliable and high-quality pharmaceutical supplies. The contract performance is scheduled for a single-day period in early 2026, reflecting a precise and timely fulfillment requirement.
Description
8511914695!ERYTHROMYCIN OPHTHA